Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for tumor treatment using CD3XCD20 bispecific antibody

Methods for tumor treatment using CD3XCD20 bispecific antibody

US Patent 10662244 · Granted May 26, 2020

Estimated economic value: $559,970,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibodies comprising chimeric constant domains2025
Heavy chain constant regions with reduced binding to Fc gamma receptors2025
Methods for treatment using chimeric antigen receptors specific for B-cell matur2025
Intralesional administration of PD-1 inhibitors for treating skin cancer2025
Bispecific anti-PSMA x anti-CD28 antibodies and uses thereof2025
Chimeric antigen receptors specific for B-cell maturation antigen and encoding p2025
Non-human animals expressing humanized CD3 complex2025
Non-human animals expressing humanized CD3 complex2025
Mouse having a humanized cluster of differentiation 47 gene2025
Antigen binding molecule formats2025
Antigen binding molecule formats2025
Combination therapy to treat brain cancer2025